Health News

Patients at Virginia G. Piper Cancer Center Clinical Trials are the first in the nation to participate in a clinical trial to determine the safety, tolerability and preliminary activity of an investigational drug that targets cell-signaling proteins associated with the most common form of lung cancer, as well as other forms of cancer such as lymphomas and neuroblastoma.

Read more

Filed under: Pharmacy News
Tags: cancer, Drug, Pharmacy, Protein

Related posts

• What Protein And Where It Is Located Are Important For Drug Design (0)
  Drugs that target a single signaling pathway that drives tumor development and/or progression have been developed successfully to treat a few forms of cancer. However, in many cases drugs designed using this approach have not worked. Dario Altieri and colleagues, at the University of Massachusetts Medical School, Worcester, have now addressed this issue by using [...]
  
  
• TGen licenses ONCO-101 cancer drug to Syracuse (0)
  The Translational Genomics Research Institute has licensed its first drug, a unique compound that targets cancer tumors by modifying the actions of proteins. Read more [tags] Pharmacy News [/tags]
  
  
• Study pinpoints compounds that repress cancer gene’s activity (0)
  A research team pursuing one of the most commonly altered genes in cancer has laid a critical foundation for understanding this gene that could point the way toward developing drugs against it. A recent study of cancer genetics pointed to the gene MCL1, which encodes a protein that helps keep cells alive Read more [tags] Pharmacy News [...]
  
  
• Structure Of A Protein That Makes Cancer Cells Resistant To Chemotherapy Discovered By Scripps Scientists (0)
  A research team at the Scripps Research Institute has obtained the first glimpse of a protein that keeps certain substances, including many drugs, out of cells. The protein, called P-glycoprotein or P-gp for short, is one of the main reasons cancer cells are resistant to chemotherapy drugs. Understanding its structure may help scientists design more [...]
  
  
• Scientists develop new type of anti-cancer drug (0)
  A team of University of Hawaii Cancer Center scientists led by James Turkson, Ph.D. have created a new type of anti-cancer drug named BP-1-102. The drug, which can be orally administered, targets a key protein that triggers the development of many types of cancer including lung, breast and skin cancers. Read more [tags] Pharmacy News [/tags]